Search clinical trials for: gefitinib (IRESSA™, ZD1839)
Total 175 results
-
AstraZenecaCompletedNeoplasms, Squamous CellUnited States, Czech Republic, Poland, Germany, Belgium, Taiwan, India, Serbia
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
AstraZenecaCompletedCarcinoma | Neoplasm | Non-small-cell Lung | MetastasesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); AstraZenecaTerminatedLung CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Hutchison Medipharma LimitedAstraZenecaCompletedNon-Small Cell Lung CancerChina
-
NSABP Foundation IncAstraZenecaCompletedBreast NeoplasmsUnited States
-
University of ChicagoCompletedHead and Neck CancerUnited States
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer | Cancer of the Head and NeckPoland, Germany, Hungary, United Kingdom
-
AstraZenecaCompletedPulmonary CancerKorea, Republic of
-
Indiana University School of MedicineAstraZenecaTerminatedRefractory Germ Cell Tumors Expressing EGRFUnited States
-
AstraZenecaCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedEsophageal CancerUnited States
-
University Hospital of CreteCompleted
-
AstraZenecaCompletedHead and Neck CancerSpain
-
M.D. Anderson Cancer CenterAstraZenecaCompleted
-
M.D. Anderson Cancer CenterAstraZenecaCompletedSkin CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...AstraZenecaCompletedNon-Small Cell Lung Carcinoma (NSCLC)United States
-
Weill Medical College of Cornell UniversityTerminatedHead and Neck CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI); Dana-Farber Cancer Institute; AstraZeneca; Brigham...CompletedHead and Neck CancerUnited States
-
Betta Pharmaceuticals Co., Ltd.CompletedNon-small Cell Lung CancerChina
-
University of NebraskaNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
Dartmouth-Hitchcock Medical CenterM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; AstraZeneca; Kentuckiana...CompletedNonresectable Adrenocortical CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage IIIB Non-small Cell Lung Cancer | Anaplastic Thyroid Cancer | Tongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous... and other conditionsUnited States
-
Tan Tock Seng HospitalAstraZeneca; Singapore Cancer Syndicate.Unknown
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaCompletedNon-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Bronchoalveolar Cell Lung CancerUnited States
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)CompletedGastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | WDHA SyndromeUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous MesotheliomaUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerCanada
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
AstraZenecaCompletedCaucasian Patients With EGFR Mutation Positive Advanced NSCLCBulgaria, Italy, Poland, Spain, Turkey, United Kingdom, Romania, Norway, Hungary, Portugal, Greece, Switzerland, France
-
National University Hospital, SingaporeNational Healthcare Group, SingaporeCompletedNasopharyngeal CarcinomaSingapore
-
M.D. Anderson Cancer CenterAstraZeneca; Aventis PharmaceuticalsWithdrawn
-
AstraZenecaCompletedNon-Small Cell Lung CancerPhilippines, China, Malaysia, Japan, Hong Kong, Taiwan, Thailand, Indonesia, Singapore
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult GliosarcomaUnited States
-
Sun Yat-sen UniversityWu Jieping Medical FoundationCompletedNon-small Cell Lung CancerChina
-
University Health Network, TorontoAstraZenecaCompleted
-
Tianjin Medical University Cancer Institute and...SuspendedNon Small Cell Lung CancerChina
-
AstraZenecaTerminatedNon Small Cell Lung CarcinomaItaly
-
Hunan Kelun Pharmaceutical Co., Ltd.CompletedBioequivalence Study
-
AstraZenecaTerminatedBrain Neoplasms | Non Small Cell Lung CancerItaly
-
Guangdong Provincial People's HospitalUnknownNon-Small Cell Lung Cancer | Brain Metastasis
-
AstraZenecaCompleted